Month: April 2018

Posted on

De-Identification, Reversible and Irreversible Pseudonymisation (NIST + IHE + ISO)

NISTIR 8053 De-Identification of Personal Information (Simson L. Garfinkel)
https://nvlpubs.nist.gov/nistpubs/ir/2015/NIST.IR.8053.pdf

IHE

Technical Frameworks:
 http://www.ihe.net/Technical_Frameworks/#IT

Healthcare De-Identification Handbook:
https://wiki.ihe.net/index.php/Healthcare_De-Identification_Handbook

ISO 25237

ISO/TS 25237 describes the objectives of de-identification to include:

  • secondary use of clinical data (e.g., research);
  • clinical trials and post-marketing surveillance;
  • pseudonymous care;
  • patient identification systems;
  • public health monitoring and assessment;
  • confidential patient-safety reporting (e.g., adverse drug effects);
  • comparative quality indicator reporting;
  • peer review;
  • consumer groups;
  • medical device calibration or maintenance.